ATE196083T1 - Verwendung von ferrioxamin-b zur behandlung septischen schocks - Google Patents

Verwendung von ferrioxamin-b zur behandlung septischen schocks

Info

Publication number: ATE196083T1
Authority: AT; Austria
Prior art keywords: septic shock; ferrioxamine; treating septic; treatment; disclosed
Prior art date: 1993-05-06

Application number

AT94914464T

Other languages

English (en)

Inventor

Wieslaw Mieczyslaw Kazmierski

Luis Molina

Original Assignee

Molichem Medicines Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-06

Filing date

1994-05-05

Publication date

2000-09-15

1994-05-05 Application filed by Molichem Medicines Inc filed Critical Molichem Medicines Inc

2000-09-15 Application granted granted Critical

2000-09-15 Publication of ATE196083T1 publication Critical patent/ATE196083T1/de

Links

206010040070 Septic Shock Diseases 0.000 title abstract 2
230000036303 septic shock Effects 0.000 title abstract 2
SRMBQCVUAVULDJ-UHFFFAOYSA-N ferrioxamine b Chemical compound [Fe+3].CC(=O)N([O-])CCCCCNC(=O)CCC(=O)N([O-])CCCCCNC(=O)CCC(=O)N([O-])CCCCCN SRMBQCVUAVULDJ-UHFFFAOYSA-N 0.000 title 1
229910052723 transition metal Inorganic materials 0.000 abstract 2
150000003624 transition metals Chemical class 0.000 abstract 2
208000001953 Hypotension Diseases 0.000 abstract 1
230000036543 hypotension Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/30—Copper compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Removal Of Specific Substances (AREA)
Pyrane Compounds (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Registering, Tensioning, Guiding Webs, And Rollers Therefor (AREA)
Gas Separation By Absorption (AREA)
Treatment Of Sludge (AREA)

AT94914464T 1993-05-06 1994-05-05 Verwendung von ferrioxamin-b zur behandlung septischen schocks ATE196083T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB939309387A GB9309387D0 (en)	1993-05-06	1993-05-06	Nitric oxide scavengers
PCT/GB1994/000967 WO1994026263A2 (en)	1993-05-06	1994-05-05	Use of a transition metal complex for the treatment of septic shock

Publications (1)

Publication Number	Publication Date
ATE196083T1 true ATE196083T1 (de)	2000-09-15

Family

ID=10735068

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94914464T ATE196083T1 (de)	1993-05-06	1994-05-05	Verwendung von ferrioxamin-b zur behandlung septischen schocks

Country Status (9)

Country	Link
US (3)	US6465511B1 (de)
EP (1)	EP0697864B1 (de)
JP (1)	JP3844489B2 (de)
AT (1)	ATE196083T1 (de)
AU (1)	AU6682594A (de)
CA (1)	CA2162154C (de)
DE (1)	DE69425820T2 (de)
GB (1)	GB9309387D0 (de)
WO (1)	WO1994026263A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9309387D0 (en)	1993-05-06	1993-06-16	Wellcome Found	Nitric oxide scavengers
CN1222286C (zh) *	1994-05-13	2005-10-12	孟山都公司	过亚硝酸盐分解催化剂的应用方法及其药物组合物
US6245758B1 (en)	1994-05-13	2001-06-12	Michael K. Stern	Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
BR9915174A (pt) *	1998-11-09	2001-11-06	Ira Jay Newman	Complexo de prata iÈnica
AUPP784998A0 (en) *	1998-12-21	1999-01-21	Ghadiminejad, Iraj	A low molecular weigh, non-proteinaceous compound that inhibits mitogen induced cytokine production
US20040101488A1 (en) *	2000-03-24	2004-05-27	Balaram Ghosh	Method for the prevention of septic shock lethality using curcumin
FR2825920B1 (fr) *	2001-06-15	2006-04-28	Oreal	Desferal comme inhibiteur de no-synthase et utilisations
AU2003217862A1 (en) *	2002-03-01	2003-09-16	Luis Molina	Treatment of septic shock
RU2353372C2 (ru) *	2003-02-20	2009-04-27	Сетек Ко., Лтд.	Акцептор перекисных анионов
US20050220862A1 (en) *	2004-03-31	2005-10-06	Bernstein Joel E	Compositions with reduced hepatotoxicity
BG65787B1 (bg)	2004-11-23	2009-11-30	Чавдар ВАСИЛЕВ	Средство за повишаване на антиген-свързващата активност на имуноглобулинови препарати
US8214310B2 (en)	2005-05-18	2012-07-03	International Business Machines Corporation	Cross descriptor learning system, method and program product therefor
EP2467135B1 (de) *	2009-08-19	2017-02-01	Mordechai Chevion	Desferrioxamin-metallkomplexe und verfahren zur behandlung von immunerkrankungen
AU2013286876B2 (en) *	2012-07-03	2017-04-20	Jay Pravda	Methods for treating, diagnosing and/or monitoring progression of oxo associated states
US9382151B2 (en)	2014-01-31	2016-07-05	Corning Incorporated	Low expansion silica-titania articles with a Tzc gradient by compositional variation
US12053511B2 (en)	2016-11-30	2024-08-06	Board Or Regents, The University Of Texas System	Cystatin C and Cystatin 9 to treat gut inflammation caused by thermal injury
US20250127740A1 (en) *	2021-11-09	2025-04-24	Arizona Board Of Regents On Behalf Of The University Of Arizona	Composition containing 3-hydroxyanthranilic acid and compounds that alter iron homeostasis and method of its use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2891854A (en) *	1954-06-16	1959-06-23	Geigy Chem Corp	Chelated iron compositions
US4451442A (en)	1982-06-21	1984-05-29	The Dow Chemical Company	Removal of hydrogen sulfide from fluid streams with minimum production of solids
US5227405A (en) *	1987-03-31	1993-07-13	Duke University	Superoxide dismutase mimic
US5223538A (en) *	1987-03-31	1993-06-29	Duke University	Superoxide dismutase mimic
DE3842143A1 (de)	1988-12-15	1990-06-21	Nitsche Dietrich	Verwendung von transferrin zur endotoxinneutralisation
US5296466A (en) *	1992-02-19	1994-03-22	Board Of Regents, The University Of Texas System	Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
GB9309387D0 (en)	1993-05-06	1993-06-16	Wellcome Found	Nitric oxide scavengers

1993
- 1993-05-06 GB GB939309387A patent/GB9309387D0/en active Pending
1994
- 1994-05-05 AU AU66825/94A patent/AU6682594A/en not_active Abandoned
- 1994-05-05 EP EP94914464A patent/EP0697864B1/de not_active Expired - Lifetime
- 1994-05-05 CA CA002162154A patent/CA2162154C/en not_active Expired - Fee Related
- 1994-05-05 JP JP52511694A patent/JP3844489B2/ja not_active Expired - Fee Related
- 1994-05-05 AT AT94914464T patent/ATE196083T1/de active
- 1994-05-05 DE DE69425820T patent/DE69425820T2/de not_active Expired - Fee Related
- 1994-05-05 WO PCT/GB1994/000967 patent/WO1994026263A2/en not_active Ceased
1997
- 1997-08-27 US US08/921,997 patent/US6465511B1/en not_active Expired - Fee Related
2001
- 2001-10-05 US US09/971,079 patent/US20020091113A1/en not_active Abandoned
2002
- 2002-08-06 US US10/212,906 patent/US7022734B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
GB9309387D0 (en)	1993-06-16
US20020091113A1 (en)	2002-07-11
AU6682594A (en)	1994-12-12
US6465511B1 (en)	2002-10-15
US7022734B2 (en)	2006-04-04
DE69425820T2 (de)	2001-03-22
WO1994026263A2 (en)	1994-11-24
EP0697864B1 (de)	2000-09-06
CA2162154C (en)	2007-03-20
JPH08510449A (ja)	1996-11-05
CA2162154A1 (en)	1994-11-24
DE69425820D1 (de)	2000-10-12
JP3844489B2 (ja)	2006-11-15
EP0697864A1 (de)	1996-02-28
WO1994026263A3 (en)	1995-01-05
US20030008856A1 (en)	2003-01-09

Similar Documents

Publication	Publication Date	Title
ATE196083T1 (de)	2000-09-15	Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE122009000012I1 (de)	2011-12-01	Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ATE194593T1 (de)	2000-07-15	3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten
DE3579113D1 (de)	1990-09-13	Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE3779149D1 (de)	1992-06-25	Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE68912781D1 (de)	1994-03-10	Verfahren und zusammensetzungen für die behandlung und zur verhütung von septischen schock.
DE69521620D1 (de)	2001-08-09	Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DE69427869D1 (de)	2001-09-06	Botulinumtoxine zur behandlung von hyperhydrosis
DE69826695D1 (de)	2004-11-04	Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE233738T1 (de)	2003-03-15	Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten
PL343495A1 (en)	2001-08-27	Heterocyclically substituted amides used as calpain inhibitors
DE69109560D1 (de)	1995-06-14	Fungizide Zusammensetzung zur Behandlung von Saatgut.
TR200200068T2 (tr)	2002-05-21	Nematisital triflüorobütenler
ATE311853T1 (de)	2005-12-15	Verwendung von krillenzymen zur behandlung von zahnbelag
AP9100310A0 (en)	1993-02-01	Tnf inhibitors
DE69328025D1 (de)	2000-04-13	Dorsalgewebe beeinflussender faktor und zusammensetzungen
MX9101958A (es)	1992-07-08	Inhibidores de acat de urea de aminosulfonilo
TR200200278T2 (tr)	2002-06-21	Kalsilitik bileşimler
DE68913995D1 (de)	1994-04-21	Zusammensetzung zur behandlung progressiver myopie.
ATE208202T1 (de)	2001-11-15	Verwendung von dimeticon zur behandlung der konstipation
UA26438A (uk)	1999-08-30	СПОСІБ ОТРИМАHHЯ СУЛЬФОHІЛФЕHІЛ- БЕttА-D-ТІОКСИЛОЗИДІВ
DE69936779D1 (de)	2007-09-20	Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen
DE69601154D1 (de)	1999-01-28	Zubereitungen für die Behandlung von Hepatitis C
DE69810906D1 (de)	2003-02-27	Optisch aktive 2-amino-tetraline, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten und die nützlich sind zur vorbeugung und behandlung von septischem schock
DE69906701D1 (de)	2003-05-15	Topische verwendung von loperamid zur behandlung mikrobieller infektionen